"Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases.
| Descriptor ID |
D014612
|
| MeSH Number(s) |
D20.215.894
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Vaccines".
This graph shows the total number of publications written about "Vaccines" by people in this website by year, and whether "Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2004 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 3 | 1 | 4 |
| 2012 | 1 | 3 | 4 |
| 2013 | 3 | 0 | 3 |
| 2014 | 3 | 3 | 6 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 0 | 3 |
| 2018 | 1 | 1 | 2 |
| 2020 | 1 | 1 | 2 |
| 2021 | 7 | 0 | 7 |
| 2022 | 9 | 1 | 10 |
| 2023 | 7 | 0 | 7 |
| 2024 | 5 | 1 | 6 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaccines" by people in Profiles.
-
No Vaccine, No Organ? Ethics of Vaccine Mandates for Pediatric Transplant. Pediatr Transplant. 2025 Feb; 29(1):e70019.
-
Vaccination uptake among post-treatment cancer survivors: A multi-vaccine scoping review. Vaccine. 2024 Sep 17; 42(22):125995.
-
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results. Nat Med. 2024 Apr; 30(4):1013-1022.
-
Lung type 3 innate lymphoid cells respond early following Mycobacterium tuberculosis infection. mBio. 2024 Apr 10; 15(4):e0329923.
-
Therapeutic synthetic and natural materials for immunoengineering. Chem Soc Rev. 2024 Feb 19; 53(4):1789-1822.
-
rWTC-MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic Cells. Adv Sci (Weinh). 2024 Apr; 11(14):e2308280.
-
Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy. J Immunol. 2024 01 15; 212(2):188-198.
-
Glycosylation-modified antigens as a tolerance-inducing vaccine platform prevent anaphylaxis in a pre-clinical model of food allergy. Cell Rep Med. 2024 01 16; 5(1):101346.
-
Mpox in people with past infection or a complete vaccination course: a global case series. Lancet Infect Dis. 2024 Jan; 24(1):57-64.
-
Cell-targeted vaccines: implications for adaptive immunity. Front Immunol. 2023; 14:1221008.